Olema Pharmaceuticals: Pay

Olema Pharmaceuticals paid its 3 named executives $7.1M in total in FY2025 (Dec). CEO Sean Bohen, M.D., Ph.D. was paid $3.2M of that.

Pay$100 in the stock at the end of FY21 → $267
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Sean Bohen, M.D., Ph.D.President and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Shawnte Mitchell, J.D.Chief Legal Officer and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
2 years
Shane KovacsChief Operating and Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 14 peers with pay on file was $5.9M. The CEO of Olema Pharmaceuticals was paid $3.2M, 46% below the median.

  1. 1Cogent Biosciences
  2. 2Arcus Biosciences
  3. 3Praxis Precision Medicines
  4. 4MeiraGTx Holdings
  5. 5Vir Biotechnology
  6. 6Arvinas
  7. 7Anaptysbio
  8. 8Oric Pharmaceuticals
  9. 9Cullinan Therapeutics
  10. 10Kura Oncology
  11. 11Relay Therapeutics
  12. 12Annexon
  13. 13Olema Pharmaceuticals
  14. 14Keros Therapeutics
  15. 15Verastem
  16. 16AlectorNot disclosed
  17. 17AlumisNot disclosed
  18. 18Amylyx Pharmaceuticals (amlx)Not disclosed
  19. 19Arcturus Therapeutics HoldingsNot disclosed
  20. 20Aura BiosciencesNot disclosed
  21. 21ErascaNot disclosed
  22. 22Inhibrx BiosciencesNot disclosed
  23. 23KalVista PharmaceuticalsNot disclosed
  24. 24Kodiak SciencesNot disclosed
  25. 25Nuvation BioNot disclosed
  26. 26Syndax PharmaceuticalsNot disclosed
  27. 27Terns PharmaceuticalsNot disclosed
  28. 28XencorNot disclosed
  29. 29Zenas BioPharmaNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.